Key statistics dashboard for Evolus, Inc. (EOLS). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc.
Stock Data
| Price | $7.99 |
| Market Cap | $526M |
| Enterprise Value | $645.8M |
| Beta | 1.00 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -15.34 |
| Price / Book | -16.95 |
| P/S | 1.65 |
| EV/EBITDA | -63.12 |
| EV/Sales | 2.04 |
| EV/FCF | -32.02 |
| P/FCF | -25.94 |
| Earnings Yield | -6.52% |
| FCF Yield | -3.83% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 66.25% |
| EBIT Margin | -5.52% |
| EBITDA Margin | -3.23% |
| Operating Margin | -7.33% |
| Net Margin | -10.85% |
| Return on Equity | 123.11% |
| Return on Assets | -13.84% |
| Return on Invested Capital | -15.27% |
| Return on Capital Employed | -15.54% |
Financial Health
| Current Ratio | 1.70 |
| Quick Ratio | 1.28 |
| Cash Ratio | 0.46 |
| Debt / Equity | -5.33 |
| Debt / Assets | 66.45% |
| Net Debt / EBITDA | -11.69 |
| Interest Coverage | -1.43 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -1.94 |
Per-Share Data
| Revenue per share | 4.80 |
| Book Value per share | -0.47 |
| Cash per share | 0.69 |
| FCF per share | -0.31 |
| Tangible Book Value per share | -1.48 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 11 |
| Hold | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 13 |
| Avg rating (1-5) | 0.85 |
Related companies: AUTL · CBLL · EHAB · KIDS · KMDA · NGNE · QSI
Explore sector: Healthcare · Drug Manufacturers - Specialty & Generic
More sections of EOLS: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks